Knight Therapeutics’ (TSE:GUD) Accumulate Rating Reaffirmed at Bloom Burton PressOracle
Bloom Burton reissued their accumulate rating on shares of Knight Therapeutics (TSE:GUD) in a research note issued to investors on Friday, November 9th.
Knight Therapeutics’ (TSE:GUD) Accumulate Rating Reaffirmed at Bloom Burton PressOracle
Bloom Burton reissued their accumulate rating on shares of Knight Therapeutics (TSE:GUD) in a research note issued to investors on Friday, November 9th.